Methods of prophylactic treatment using recombinant VWF (rVWF)
US12128090B2 · kind B2 · utility
0Cited by
19References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2020 |
| Grant date | Oct 29, 2024 |
| Priority date | — |
| Expiry date | Jan 31, 2040 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/755
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method for prophylactic treatment of spontaneous bleeding in a subject with severe von Willebrand Disease comprising administering a therapeutic amount of recombinant von Willebrand Factor (rVWF) to the subject.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.